GENOWAY – The board of directors of genOway proposes the appointment of Olivier Charmeil as director – 23-05-22 – 18h00

Lyon (France) – May 23, 2022 – genOway (Euronext GrowthTM -ALGAE ISIN: FR0004053510)a biotechnology company specialized in the design and development of genetically modified research models, announces the decision of the Board of Directors to propose the appointment of Mr. Olivier Charmeil,Executive Vice President of Sanofi, as new independent director. This appointment will be put … Read more